Bonate, P. L.

Population pharmacokinetics–pharmacodynamics of alemtuzumab (Campath ® ) in patients with chronic lymphocytic leukaemia and its link to treatment response

Mould, D. R., Baumann, A., Kuhlmann, J., Keating, M. J., Weitman, S., Hillmen, P., Brettman, L. R., Reif, S., & Bonate, P. L. (2007) · British Journal of Clinical Pharmacology

Chronic Lymphocytic Leukemia ResearchPharmaceutical studies and practices

Cited by 116

Guidelines for the Quality Control of Population Pharmacokinetic–Pharmacodynamic Analyses: an Industry Perspective

Bonate, P. L., Strougo, A., Desai, A., Roy, M., Yassen, A., van der Walt, J. S., Kaibara, A., & Tannenbaum, S. (2012) · The AAPS Journal

Pharmaceutical studies and practicesStatistical Methods in Clinical Trials

Cited by 39